Document Detail

Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review.
MedLine Citation:
PMID:  21295641     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Acute pancreatitis is a common complication of ERCP. Several randomized, controlled trials (RCTs) have evaluated the use of pancreatic stents in the prevention of post-ERCP pancreatitis with varying results.
OBJECTIVE: We conducted a meta-analysis and systematic review to assess the role of prophylactic pancreatic stents for prevention of post-ERCP pancreatitis.
DESIGN: MEDLINE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, PubMed, and recent abstracts from major conference proceedings were searched. RCTs and retrospective or prospective, nonrandomized studies comparing prophylactic stent with placebo or no stent for post-ERCP pancreatitis were included for the meta-analysis and systematic review. Standard forms were used to extract data by 2 independent reviewers. The effect of stents (for RCTs) was analyzed by calculating pooled estimates of post-ERCP pancreatitis, hyperamylasemia, and grade of pancreatitis. Separate analyses were performed for each outcome by using the odds ratio (OR) or weighted mean difference. Random- or fixed-effects models were used. Publication bias was assessed by funnel plots. Heterogeneity among studies was assessed by calculating I(2) measure of inconsistency.
SETTING: Systematic review and meta-analysis of patients undergoing pancreatic stent placement for prophylaxis against post-ERCP pancreatitis.
PATIENTS: Adult patients undergoing ERCP.
INTERVENTIONS: Pancreatic stent placement for the prevention of post-ERCP pancreatitis.
MAIN OUTCOME MEASUREMENTS: Post-ERCP pancreatitis, hyperamylasemia, and complications after pancreatic stent placement.
RESULTS: Eight RCTs (656 subjects) and 10 nonrandomized studies met the inclusion criteria (4904 subjects). Meta-analysis of the RCTs showed that prophylactic pancreatic stents decreased the odds of post-ERCP pancreatitis (odds ratio, 0.22; 95% CI, 0.12-0.38; P<.01). The absolute risk difference was 13.3% (95% CI, 8.8%-17.8%). The number needed to treat was 8 (95% CI, 6-11). Stents also decreased the level of hyperamylasemia (WMD, -309.22; 95% CI, -350.95 to -267.49; P≤.01). Similar findings were also noted from the nonrandomized studies.
LIMITATIONS: Small sample size of some trials, different types of stents used, inclusion of low-risk patients in some studies, and lack of adequate study of long-term complications of pancreatic stent placement.
CONCLUSIONS: Pancreatic stent placement decreases the risk of post-ERCP pancreatitis and hyperamylasemia in high-risk patients.
Abhishek Choudhary; Matthew L Bechtold; Murtaza Arif; Nicholas M Szary; Srinivas R Puli; Mohamed O Othman; Wilson P Pais; Mainor R Antillon; Praveen K Roy
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review    
Journal Detail:
Title:  Gastrointestinal endoscopy     Volume:  73     ISSN:  1097-6779     ISO Abbreviation:  Gastrointest. Endosc.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-07     Completed Date:  2011-06-16     Revised Date:  2012-04-26    
Medline Journal Info:
Nlm Unique ID:  0010505     Medline TA:  Gastrointest Endosc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  275-82     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
University of Missouri School of Medicine, Columbia, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Pancreas / surgery*
Pancreatitis / etiology,  prevention & control*
Comment In:
Endoscopy. 2012 Apr;44(4):389-93   [PMID:  22438149 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with ...
Next Document:  Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review.